Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 11, 2021 16:30 ET | Source: Profound Medical Corp.

Profound Medical to Participate in the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

TORONTO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free...
February 09, 2021 16:30 ET | Source: Profound Medical Corp.

Profound Medical to Release Fourth Quarter and Full Year 2020 Financial Results on March 2 – Conference Call to Follow

TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free...
January 05, 2021 16:30 ET | Source: Profound Medical Corp.

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2020 Revenues

TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free...
December 21, 2020 07:30 ET | Source: Profound Medical Corp.

Profound Medical Signs Agreement with GE Healthcare to Expand Provider Access to TULSA-PRO®

TORONTO, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
November 30, 2020 08:00 ET | Source: Profound Medical Corp.

Profound Medical Receives FDA HDE Approval for Sonalleve®

TORONTO, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) announced today that Sonalleve® has received U.S. Food and Drug Administration...
November 30, 2020 07:45 ET | Source: Profound Medical Corp.

Profound Medical Announces Changes to its Board of Directors

TORONTO, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
November 10, 2020 16:30 ET | Source: Profound Medical Corp.

Profound Medical to Participate in November Virtual Investor Healthcare Conferences

TORONTO, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
November 05, 2020 16:02 ET | Source: Profound Medical Corp.

Profound Medical Announces Third Quarter 2020 Financial Results

TORONTO, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
October 15, 2020 16:30 ET | Source: Profound Medical Corp.

Profound Medical to Release Third Quarter 2020 Financial Results on November 5 – Conference Call to Follow

TORONTO, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
September 09, 2020 16:30 ET | Source: Profound Medical Corp.

Profound Medical to Present at the Cantor Virtual Global Healthcare Conference

TORONTO, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...